Viewing Study NCT04306367


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-05 @ 6:01 PM
Study NCT ID: NCT04306367
Status: COMPLETED
Last Update Posted: 2025-02-17
First Post: 2020-02-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Sponsor: Georgetown University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cholangiocarcinoma View